$9.47
2.71% today
NYSE, Aug 12, 04:47 pm CET
ISIN
US30050B1017
Symbol
EVH

Evolent Health Inc Class A Stock price

$9.22
-1.96 17.53% 1M
-0.64 6.49% 6M
-2.03 18.04% YTD
-16.07 63.54% 1Y
-26.64 74.29% 3Y
-4.21 31.35% 5Y
-10.38 52.96% 10Y
-9.64 51.11% 20Y
NYSE, Closing price Mon, Aug 11 2025
+0.22 2.44%
ISIN
US30050B1017
Symbol
EVH

Key metrics

Basic
Market capitalization
$1.1b
Enterprise Value
$1.7b
Net debt
$572.8m
Cash
$246.6m
Shares outstanding
115.9m
Valuation (TTM | estimate)
P/E
negative | 25.9
P/S
0.5 | 0.5
EV/Sales
0.7 | 0.8
EV/FCF
negative
P/B
1.0
Financial Health
Equity Ratio
46.8%
Return on Equity
-7.8%
ROCE
1.2%
ROIC
1.1%
Debt/Equity
0.7
Financials (TTM | estimate)
Revenue
$2.4b | $2.1b
EBITDA
$135.3m | $152.9m
EBIT
$22.3m | $86.5m
Net Income
$-140.5m | $41.3m
Free Cash Flow
$-9.7m
Growth (TTM | estimate)
Revenue
10.3% | -18.7%
EBITDA
-7.0% | 32.0%
EBIT
3.0% | 3,452.8%
Net Income
0.5% | 144.2%
Free Cash Flow
-107.5%
Margin (TTM | estimate)
Gross
15.3%
EBITDA
5.6% | 7.4%
EBIT
0.9%
Net
-5.9% | 2.0%
Free Cash Flow
-0.4%
More
EPS
$-1.2
FCF per Share
$-0.1
Short interest
15.1%
Employees
5k
Rev per Employee
$570.0k
Show more

Is Evolent Health Inc Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Evolent Health Inc Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Evolent Health Inc Class A forecast:

16x Buy
89%
2x Hold
11%

Analyst Opinions

18 Analysts have issued a Evolent Health Inc Class A forecast:

Buy
89%
Hold
11%

Financial data from Evolent Health Inc Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
2,399 2,399
10% 10%
100%
- Direct Costs 2,033 2,033
18% 18%
85%
366 366
18% 18%
15%
- Selling and Administrative Expenses 235 235
17% 17%
10%
- Research and Development Expense - -
-
-
135 135
7% 7%
6%
- Depreciation and Amortization 113 113
9% 9%
5%
EBIT (Operating Income) EBIT 22 22
3% 3%
1%
Net Profit -140 -140
1% 1%
-6%

In millions USD.

Don't miss a Thing! We will send you all news about Evolent Health Inc Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Evolent Health Inc Class A Stock News

Neutral
Seeking Alpha
4 days ago
Evolent Health, Inc. (NYSE:EVH ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants John Paul Johnson - Chief Financial Officer Seth Barrie Blackley - Co-Founder, CEO & Director Conference Call Participants Charles Rhyee - TD Cowen, Research Division Daniel R. Grosslight - Citigroup Inc., Research Division Eduardo Enrique Ron - Truist Securities, Inc., Research Divi...
Neutral
The Motley Fool
5 days ago
EVH Earnings Drop 31%
Neutral
PRNewsWire
5 days ago
WASHINGTON , Aug. 7, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the three months ended June 30, 2025. Seth Blackley, Co-Founder and Chief Executive Office...
More Evolent Health Inc Class A News

Company Profile

Evolent Health, Inc. engages in the provision of health care delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. It operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.

Head office United States
CEO Seth Blackley
Employees 4,500
Founded 2011
Website www.evolent.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today